Conditions of the Skin/Soft Tissue in the ER

  • I. W. FongEmail author
Part of the Emerging Infectious Diseases of the 21st Century book series (EIDC)


A 29-year-old female was presented to the emergency department of a suburban general hospital at 11 p.m. with severe pain of her left thigh. The patient had a medical history of asthma since childhood, otherwise she was well. The day before, she had an argument with her live-in boyfriend that precipitated an attack of asthma, and she gave herself an epiPen (epinephrine) intramuscular injection in the left thigh without cleansing the skin beforehand. Apparently, the epiPen injector had been in her handbag for the past 2 years and the cap was off when it was used. The pain in her left thigh had been progressing over the previous 12 h, but there was no history of fever or chills.


Compartment Syndrome Necrotizing Fasciitis Left Thigh Epinephrine Injection Lassa Fever 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Gordon RJ, Lowy FD, (2005), Bacterial infections in drug users. N Engl J Med. 353: 1945–1954.PubMedCrossRefGoogle Scholar
  2. 2.
    Kimura AC, Higa JI, Levin RM, Simpson G, Vargas Y, Vugia DJ, (2004), Outbreak of necrotizing fasciitis due to Clostriduim sordelli among black-tar heroin users. Clin. Infect. Dis. 38: e87–e91.PubMedCrossRefGoogle Scholar
  3. 3.
    Dunbar NM, Harruff RC, (2007), Necrotizing fasciitis: manifestations, microbiology, and connection with black tar heroin. J Forensic Sci. 52: 920–923.PubMedCrossRefGoogle Scholar
  4. 4.
    Werner SB, Passaro D, McGee J, Schechter R, Vugia DJ, (2000), Wound botulism in California, 1951-1998: recent epidemic in heroin injectors. Clin Infect Dis. 31:1018–1024.PubMedCrossRefGoogle Scholar
  5. 5.
    Hoeger PH, Haupt G, Hoelzle E, (1996), Acute multifocal skin necrosis: synergism between invasive streptococcal infection and cocaine-induced tissue ischemia? Acta Derm Venereol. 76: 239–241.PubMedGoogle Scholar
  6. 6.
    Eckmann C, Kujath P, Shekarriz H, Staubach KH, (1997), Clostridium myonecrosis as a sequelae of intramuscular injections--description of 3 fatal outcomes. Langenbecks Arch Chirugie; 114 (suppl.): 553–555.Google Scholar
  7. 7.
    Koons TA, Boyden GM, Albuquerque NM, (1961), Gas gangrene from parental injections. JAMA; 175: 140–141.Google Scholar
  8. 8.
    Marshall V, Sims P, (1960), Gas gangrene after the injection of adrenaline-in-oil with a report of three cases. Med. J. Aust. 2: 653–656.Google Scholar
  9. 9.
    Harvey PW, Purnell GV, (1968), Fatal case of gas gangrene associated with intramuscular injections. Brit. Med. J. 1: 744–746.PubMedCrossRefGoogle Scholar
  10. 10.
    Gaylis H, (1968), Gas gangrene and intramuscular injection. Brit. Med. J. 3: 59–60.PubMedCrossRefGoogle Scholar
  11. 11.
    Maguire WB, Langley NF, (1967), Gas gangrene following an adrenaline-in-oil injection into the left thigh with survival. Med. J. Aust. 1: 973–975.PubMedGoogle Scholar
  12. 12.
    Van Hook R, Vandevelde AG, (1975), Gas gangrene after intramuscular injection of epinephrine: report of fatal case. Ann. Intern. Med. 83: 669–670.PubMedGoogle Scholar
  13. 13.
    Teo WS, Balasubramaniam P, (1983), Gas gangrene after intramuscular injection of adrenaline. Clin. Orthop. Relat. Res. 174: 206–207.PubMedGoogle Scholar
  14. 14.
    Hallagan LF, Scott JL, Horowitz BC, Feied CF, (1992), Clostridial myonecrosis resulting from subcutaneous epinephrine suspension injection. Ann. Emerg. Med. 4: 434–436.CrossRefGoogle Scholar
  15. 15.
    Mabin G, (1936), La gangrene gazeuse après injections medicamenteuses. Thèse de Paris.Google Scholar
  16. 16.
    Touraine A, (1936), La gangrene gazeuse après injections medicamenteuses. Presse Med. 44: 674–677.Google Scholar
  17. 17.
    Koransky JR, Stargel MD, Dowell VR Jr, (1979), Clostridium septicum bacteremia, its clinical significance. Am. J. Med. 66: 63–66.PubMedCrossRefGoogle Scholar
  18. 18.
    Collier PE, Diamond DL, Young JC, (1983), Nontraumatic Clostridium septicum gangrenous myonecrosis. Dis. Colon. Rectum. 26: 703–704.PubMedCrossRefGoogle Scholar
  19. 19.
    Katlic MR, Derkac WM, Coleman WS, (1981), Clostridium septicum infection and malignancy. Ann. Surg. 193: 361–364.PubMedCrossRefGoogle Scholar
  20. 20.
    Stevens DL, Musher DM, Watson DA, Eddy H, Hamill RJ, Gyorkey F, Rosen H, Mader JT, (1990), Spontaneous, non-traumatic gangrene due to Clostridium septicum. Rev. Infect. Dis. 12: 286–296.PubMedCrossRefGoogle Scholar
  21. 21.
    Bretzke ML, Bubrick MP, Hitchcock CR, (1988), Diffuse spreading Clostridium septicum infection, malignant disease and immune suppression. Surg. Gynecol. Obstet. 166: 197–199.PubMedGoogle Scholar
  22. 22.
    Thomas MG, (1990), Clostridium septicum gas gangrene following intramuscular infection from an influenza vaccine booster. Br J. Clin. Pract. 44: 709–710.PubMedGoogle Scholar
  23. 23.
    Ray P, Das A, Singh K, Bhansali A, Yadav TD, (2003), Clostridium tertium in necrotizing fasciitis and gangrene. Emerg. Infect. Dis. 9:1347–1348.PubMedGoogle Scholar
  24. 24.
    Bhargava A, Sen P, Swaminathan A, Ogbolu C, Chechko S, Stone F, (2000), Rapidly progressive necrotizing fasciitis and gangrene due to Clostridium difficile: case report. Clin. Infect. Dis. 30: 954–955.PubMedCrossRefGoogle Scholar
  25. 25.
    Willis AT, (1974), Some infections due to anaerobic spore forming bacilli. In: Balows A, Deehaan RM, Dowell VR Jr, Gaze L (eds), Anaerobic bacteria: role in disease. Charles C. Thomas Publisher, Springfield, Illinois, p195–217.Google Scholar
  26. 26.
    Mittermair RP, Schoberberger W, Hasibeder W, Allerberger F, Peer R, Bonatti H, (2002), Necrotizing fasciitis with Clostridium perfringens after laparoscopic cholecystectomy. Surg. Endoscopy; 16: 716.PubMedCrossRefGoogle Scholar
  27. 27.
    Lorber B, (2000), Gas gangrene and other Clostridium-associated disease. In: Mandell GL, Bennett JE, Dolin R (eds), Principles and Practice of infectious Diseases, 5th Edition, Churchill Livingstone, Philadelphia, p 2549–2561.Google Scholar
  28. 28.
    Anonymous, (1961), Gas gangrene from adrenaline (editorial). Brit. Med. J. 730–731.Google Scholar
  29. 29.
    Stevens DL, Bryant AE, (1999), The pathogenesis of shock and tissue injury in clostridial gas gangrene. In: Alouf JE, Freer JH (eds). The comprehensive sourcebook of bacterial protein toxins. 2nd Edition, Academic Press, London; 623–636.Google Scholar
  30. 30.
    Bryant AE, Chen RY, Nagata Y, Wang Y, Lee CH, Finegold S, Guth PH, Stevens DL, (2000), Clostridial gas gangrene. I. Cellular and molecular mechanisms of microvascular dysfunction induced by exotoxins of Clostridium perfringens. J. Infect. Dis. 182: 799–807.PubMedCrossRefGoogle Scholar
  31. 31.
    Bryant AE, Chen RY, Nagata Y, Wang Y, Lee CH, Finegold S, Guth PH, Stevens DL, (2000), Clostridial gas gangrene. II. Phospholipase C-induced activation of platelet gpIIbIIIa mediates vascular occlusion and myonecrosis in Clostridium perfringens gas gangrene. J. Infect. Dis. 182: 808–815.PubMedCrossRefGoogle Scholar
  32. 32.
    Bryant AE, Bergstrom R, Zimmerman GA, Salyer JL, Hill HR, Tweten RK, Sato H, Stevens DL, (1993), Clostridium perfringens invasiveness is enhanced by effects of theta toxin upon PMNL structure and function: the roles of leukocytotoxicity and expression of CD11/CD18 adherence glycoprotein. FEMS Immunol. Med. Microbiol. 7: 321–336.PubMedCrossRefGoogle Scholar
  33. 33.
    Altemeier WA, Fullen WD, (1971), Prevention and treatment of gas gangrene. JAMA; 217: 806–813.PubMedCrossRefGoogle Scholar
  34. 34.
    Cline KA, Turnbull TL, (1985), Clostridial myonecrosis. Ann. Emerg. Med. 14: 459–466.PubMedCrossRefGoogle Scholar
  35. 35.
    Altemeier WA, McMurrin JA, ALT LP, (1950), Chloromycetin and aureomycin in experimental gas gangrene. Surgery; 28: 621–631.PubMedGoogle Scholar
  36. 36.
    Stevens DL, (2004), Skin and soft tissue infections: cellulitis, fasciitis, myonecrosis. Consultant; 44: 694–700.Google Scholar
  37. 37.
    Holder AR, (1972), Liability for gas gangrene. JAMA; 221: 1083–1084.PubMedCrossRefGoogle Scholar
  38. 38.
    Louis J, (1999), Axillary vein thrombosis mimicking muscular strain. J. Accid. Emerg. Med. 16: 233–234.PubMedGoogle Scholar
  39. 39.
    Sajid MS, Ahmed N, Desai M, Baker D, Hamilton G, (2007), Upper limb deep vein thrombosis: a literature review to streamline the protocol for management. Acta Haematol. 118: 10–18.PubMedCrossRefGoogle Scholar
  40. 40.
    Amendola A, Twaddle BC, (1998), Compartment syndrome. In: Browner BD, Jupitor JB, Levine AM, Trafton PG (eds); Skeletal Trauma, 2nd Edition, WB Saunders Company, Philadelphia; p365–389.Google Scholar
  41. 41.
    Jobe MT, (2003), Compartment syndromes and Volkmann Contracture. In: Canale ST (ed), Campbell’s Operative Orthopedics, 10th Edition, Mosby, St. Louis, p3739–3750.Google Scholar
  42. 42.
    Eron LJ, (2009), In the clinic: cellulitis and soft tissue infection. Ann. Intern. Med. 150: ITc 1–14.Google Scholar
  43. 43.
    Bisno AL, Cockerill FR III, Bermudez CT, (2000), The initial outpatient-physician encounter in group A streptococcal necrotizing fasciitis. Clin. Infect Dis. 31: 607–608.PubMedCrossRefGoogle Scholar
  44. 44.
    Arsian A, Pierre-Jerome C, Barthne A, (2000), Necrotizing fasciitis: unreliable MRI findings in the pre-operative diagnosis. Eur. J. Radiol. 36: 139–143.CrossRefGoogle Scholar
  45. 45.
    Stevens DL, Bisno AL, Chambers HF, Everett ED, Dellinger P, Goldstein EJ, Gorbach SL, Hirschmann JV, Kaplan EL, Montoya JG, Wade JC, (2005), Infectious Diseases Society of America. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin. Infect. Dis. 41: 1373–1406.PubMedCrossRefGoogle Scholar
  46. 46.
    Stevens DL, Bryant-Gibbons AE, Bergstrom R, Winn V, (1988), The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis. J Infect Dis. 158: 23–28.PubMedCrossRefGoogle Scholar
  47. 47.
    Zimbelman J, Palmer A, Todd J, (1999), Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection. Pediatr. Infect. Dis J. 18: 1096–1010.PubMedCrossRefGoogle Scholar
  48. 48.
    Kaul R, McGeer A, Norrby-Teglund A, Kotb M, Schwartz B, O'Rourke K, Talbot J, Low DE; The Canadian Streptococcal Study Group, (1999), Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome--a comparative observational study. Clin. Infect. Dis. 28: 800–807.PubMedCrossRefGoogle Scholar
  49. 49.
    Darenberg J, Ihendyane N, Sjölin J, Aufwerber E, Haidl S, Follin P, Andersson J, Norrby-Teglund A; StreptIg Study Group, (2003), Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clin. Infect. Dis. 37: 333–340.PubMedCrossRefGoogle Scholar
  50. 50.
    Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Kumar A, Cheang M, (2006), Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit. Care. Med. 34: 1589–1596.PubMedCrossRefGoogle Scholar
  51. 51.
    O'Loughlin RE, Roberson A, Cieslak PR, Lynfield R, Gershman K, Craig A, Albanese BA, Farley MM, Barrett NL, Spina NL, Beall B, Harrison LH, Reingold A, Van Beneden C; Active Bacterial Core Surveillance Team, (2007), The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin. Infect. Dis. 45: 853–862.PubMedCrossRefGoogle Scholar
  52. 52.
    Anaya DA, Dellinger EP, (2007), Necrotizing soft-tissue infection: diagnosis and management. Clin Infect Dis. 44: 705–710.PubMedCrossRefGoogle Scholar
  53. 53.
    McHenry CR, Piotrowski JJ, Petrinic D, Malangoni MA, (1995), Determinants of mortality for necrotizing soft-tissue infections. Ann. Surg. 221: 558–563.PubMedCrossRefGoogle Scholar
  54. 54.
    Bilton BD, Zibari GB, McMillan RW, Aultman DF, Dunn G, McDonald JC, (1998), Aggressive surgical management of necrotizing fasciitis serves to decrease mortality: a retrospective study. Am. Surg. 64: 397–400.PubMedGoogle Scholar
  55. 55.
    Lille ST, Sato TT, Engrav LH, Foy H, Jurkovich GJ, (1996), Necrotizing soft tissue infections: obstacles in diagnosis. J Am Coll Surg. 182: 7–11.PubMedGoogle Scholar
  56. 56.
    Majeski J, Majeski E, (1997), Necrotizing fasciitis: improved survival with early recognition by tissue biopsy and aggressive surgical treatment. South Med J. 90: 1065–1068.PubMedCrossRefGoogle Scholar
  57. 57.
    Mulla ZD, Leaverton PE, Wiersma ST, (2003), Invasive group A streptococcal infections in Florida. South. Med. J. 96: 968–973.PubMedCrossRefGoogle Scholar
  58. 58.
    Daneman N, McGeer A, Low DE, Tyrrell G, Simor AE, McArthur M, Schwartz B, Jessamine P, Croxford R, Green KA; Ontario Group A Streptococcal Study Group, (2005), Hospital-acquired invasive group a streptococcal infections in Ontario, Canada, 1992-2000. Clin. Infect. Dis. 41: 334–342.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.St. Michael’s HospitalUniversity of TorontoTorontoCanada

Personalised recommendations